Literature DB >> 21742466

The clinical profile and outcomes associated with coronary collaterals in patients with coronary artery disease.

M Sean McMurtry1, Adriane M Lewin, Merril L Knudtson, William A Ghali, P Diane Galbraith, Felix Schulte, Colleen M Norris, Michelle M Graham.   

Abstract

BACKGROUND: The clinical correlates of coronary collaterals and the effects of coronary collaterals on prognosis are incompletely understood.
METHODS: We performed a study of 55,751 patients undergoing coronary angiography to evaluate the correlates of angiographically apparent coronary collaterals, and to evaluate their association with survival.
RESULTS: The characteristic most strongly associated with the presence of collaterals was a coronary occlusion (odds ratio [OR], 28.9; 95% confidence interval [CI], 27.1-30.6). Collaterals were associated with improved adjusted survival overall (hazard ratio [HR] 0.89; 95% CI, 0.85-0.95), and in both acute coronary syndrome (ACS) (HR 0.90; 95% CI, 0.84-0.96) and non-ACS (HR 0.84; 95% CI, 0.77-0.92) patients. Collaterals were associated with improved survival in those receiving angioplasty (HR 0.78; 95% CI, 0.71-0.85) and those with low risk anatomy treated medically (HR 0.84; 95% CI, 0.72-0.98), but not for those treated with coronary bypass graft surgery or those with high-risk anatomy treated without revascularization.
CONCLUSIONS: The major correlate of coronary collaterals is the presence/extent of obstructive coronary artery disease. Collaterals are associated with better survival overall and in both ACS and non-ACS presentations, but not for those treated with coronary artery bypass graft (CABG) or those with high-risk anatomy who are not revascularized.
Copyright © 2011 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21742466     DOI: 10.1016/j.cjca.2011.02.011

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  Effects of the coronary collateral circulation on the Tp-e interval and Tp-e/QT ratio in patients with stable coronary artery disease.

Authors:  Hakan Taşolar; Mehmet Ballı; Mustafa Çetin; Yılmaz Ömür Otlu; Burak Altun; Adil Bayramoğlu
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-16       Impact factor: 1.468

2.  The presence of angiographic collaterals in non-ST elevation myocardial infarction is a predictor of long-term clinical outcomes.

Authors:  Angela M Kloepfer; Lewis C Lipson; Ellen C Keeley
Journal:  Catheter Cardiovasc Interv       Date:  2013-06-25       Impact factor: 2.692

3.  Serum Sphingosine 1 Phosphate Levels in Patients with and without Coronary Collateral Circulation.

Authors:  Emrullah Kızıltunç; Murat Gök; Canan Topçuoğlu; Harun Kundi; Mustafa Çetin; Turan Turhan; Ender Örnek
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

4.  The relationship between coronary collateral circulation and neutrophil/lymphocyte ratio in patients with coronary chronic total occlusion.

Authors:  Alper Bugra Nacar; Ali Erayman; Mustafa Kurt; Eyup Buyukkaya; Mehmet Fatih Karakaş; Adnan Burak Akcay; Sule Buyukkaya; Nihat Sen
Journal:  Med Princ Pract       Date:  2014-10-17       Impact factor: 1.927

5.  Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation.

Authors:  B B L M IJkema; J J R M Bonnier; D Schoors; M J Schalij; C A Swenne
Journal:  Neth Heart J       Date:  2014-11       Impact factor: 2.380

6.  The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarction.

Authors:  Serkan Akdag; Aytac Akyol; Muntecep Asker; Fatih Ozturk; Hasan Ali Gumrukcuoglu
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-08-19       Impact factor: 1.426

7.  Blood Group Types O and Non-O Are Associated With Coronary Collateral Circulation Development.

Authors:  Savas Celebi; Ozlem Ozcan Celebi; Berkten Berkalp; Sinan Aydogdu; Basri Amasyali
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.